XML 32 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Antidilutive Securities Excluded and Imapirment charges
Number of warrants excluded from weighted average common shares outstanding on a diluted basis.	4,480,000
Number of options excluded from weighted average common shares outstanding on a diluted basis.	4,750,000
Revenue percentage	100.00%	100.00%
Research and development costs	$ 57,725	$ 84,656
Fair value of notes	$ 400,000

X

- References

No definition available.

+ Details

Name:	pwvi_AntidilutiveSecuritiesExcludedAndImapirmentChargesAbstract
Namespace Prefix:	pwvi_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of options excluded from weighted average common shares outstanding on a diluted basis.

+ References

No definition available.

+ Details

Name:	pwvi_NumberOfOptionsExcludedFromWeightedAverageCommonSharesOutstandingOnADilutedBasis
Namespace Prefix:	pwvi_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of warrants excluded from weighted average common shares outstanding on a diluted basis.

+ References

No definition available.

+ Details

Name:	pwvi_NumberOfWarrantsExcludedFromWeightedAverageCommonSharesOutstandingOnADilutedBasis
Namespace Prefix:	pwvi_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Revenue recognition percentage.

+ References

No definition available.

+ Details

Name:	pwvi_RevenueRecognitionPercentage
Namespace Prefix:	pwvi_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13476-108611

+ Details

Name:	us-gaap_DebtInstrumentFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount of other research and development expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_OtherResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration